Brookfield Asset Management Inc. Merck & Co., Inc. Transaction History

Brookfield Asset Management Inc.

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Sep 25, 2023	SELL	$108.61 - $118.38 $17.6 Million - $19.1 Million	-161,708 Reduced 82.94%	33,258 $3.84 Million
Q2 2023 Aug 14, 2023	SELL	$108.61 - $118.38 $17.6 Million - $19.1 Million	-161,708 Reduced 82.94%	33,258 $3.84 Million
Q1 2023 Sep 25, 2023	BUY	$102.94 - $114.86 $16.6 Million - $18.6 Million	161,708 Added 486.22%	194,966 $20.7 Million
Q1 2023 May 15, 2023	BUY	$102.94 - $114.86 $11 Million - $12.3 Million	107,282 Added 122.35%	194,966 $20.7 Million
Q4 2022 Feb 14, 2023	SELL	$87.44 - $112.11 $2.21 Million - $2.84 Million	-25,305 Reduced 22.4%	87,684 $9.73 Million
Q3 2022 Nov 14, 2022	BUY	$84.53 - $94.96 $4.53 Million - $5.09 Million	53,642 Added 90.39%	112,989 $9.73 Million
Q2 2022 Nov 16, 2022	SELL	$83.49 - $94.64 $4.48 Million - $5.08 Million	-53,642 Reduced 47.48%	59,347 $5.41 Million
Q2 2022 Aug 15, 2022	SELL	$83.49 - $94.64 $8.34 Million - $9.45 Million	-99,845 Reduced 62.72%	59,347 $5.41 Million
Q3 2021 Nov 16, 2021	BUY	$71.68 - $78.83 $11.4 Million - $12.5 Million	159,192 New	159,192 $12 Million

3,820

1.88B

15.6M

13.7M

Ticker MRK
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,533,280,000
Market Cap $253B
Description
Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, ...

Get notified when there are updates to the investment portfolio of Brookfield Asset Management Inc., based on Form 13F filings with the SEC.

Stay updated on Brookfield Asset Management Inc. with notifications on news.